ACOT9 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACOT9 monoclonal antibodies for research focused on understanding acyl-CoA thioesterases. ACOT9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACOT9, a member of the acyl-CoA thioesterase family, plays a crucial role in lipid metabolism by hydrolyzing acyl-CoA thioesters, thereby regulating fatty acid availability and signaling pathways. ACOT9 maintains cellular lipid homeostasis and influences metabolic processes, making it a significant target for research in metabolic disorders and cancer. Researchers investigating ACOT9 can explore its expression patterns across different tissues and cell types. Understanding ACOT9's regulatory mechanisms can provide valuable information about its role in normal physiology and disease states. ACOT9 research has revealed important connections to mitochondrial function and energy metabolism. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of metabolic pathways and potential therapeutic targets.